Asia-Pacific countries sharpen antimicrobial resistance plans, but 49% of plans in 27 countries are not costed
5 October 2026
An article published on 5 October 2026 in BMJ Public Health uses data from 28 Asia-Pacific countries on antimicrobial resistance (AMR) action plans.
Of the 28 countries, 27 had endorsed at least one multisectoral AMR action plan.
Second-generation plans were twice as likely to be costed as first plans (67% versus 33%).
Nearly half (49%) of the 27 countries with AMR plans are not costed at all; 44% of plans are fully costed and another 7% partially costed.
Only eight countries reported that AMR activities are funded entirely from domestic sources.
The findings are the first regional summary of progress against the 2024 UN General Assembly Political Declaration on AMR.
In plain words
AMR Antimicrobial resistance — When bacteria and other organisms evolve to resist the medicines used to treat infections.